Tolvaptan treatment for severe neonatal autosomal-dominant polycystic kidney disease

[1]  C. Férec,et al.  Type of PKD1 mutation influences renal outcome in ADPKD. , 2013, Journal of the American Society of Nephrology : JASN.

[2]  K. Lachlan,et al.  Bilineal inheritance of PKD1 abnormalities mimicking autosomal recessive polycystic disease , 2013, Pediatric Nephrology.

[3]  Eiji Higashihara,et al.  Tolvaptan in patients with autosomal dominant polycystic kidney disease. , 2012, The New England journal of medicine.

[4]  E. Bongers,et al.  Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy , 2011, Journal of Medical Genetics.

[5]  J. Jonsson,et al.  Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[6]  J. Glockner,et al.  Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease. , 2011, Kidney international.

[7]  P. Igarashi,et al.  Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases , 2011, Proceedings of the National Academy of Sciences.

[8]  R. Schrier,et al.  Magnetic resonance imaging of kidney and cyst volume in children with ADPKD. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[9]  E. J. van der Jagt,et al.  Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[10]  E. Ars,et al.  Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. , 2010, Journal of the American Society of Nephrology : JASN.

[11]  W. Guggino,et al.  cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. , 2000, Journal of the American Society of Nephrology : JASN.

[12]  E. Henske,et al.  Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. , 1997, The Journal of clinical investigation.

[13]  S. Norby,et al.  Autosomal dominant polycystic kidney disease in the 1980's , 1989, Clinical genetics.

[14]  Ge Wang.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Fractal MapReduce decomposition of sequence alignment , 2005 .